Bentley Pharmaceuticals lists on NYSE

Bentley Pharmaceuticals, Inc. (AMEX: BNT), a specialty pharmaceutical company focused on advanced drug-delivery technologies, which also manufactures and markets generic and branded products in Europe, announced today that it has applied to list its common stock on the New York Stock Exchange (NYSE).  The Company anticipates that its common stock will begin trading on the NYSE on Wednesday, May 12, 2004, under its current ticker symbol, “BNT.”  Bentley’s common stock will continue to trade on the American Stock Exchange until that date.

James R. Murphy, Bentley’s President and CEO, commented, “We look forward to continuing our growth and development on the NYSE, which will assist us in achieving our goal of providing long-term value to our shareholders. We are also honored to be associated with so many other quality companies with which we share common beliefs and goals including: providing value to our shareholders; establishing a global market presence; building a strong financial position; and continuing to comply with sound business practices.  We believe that our listing on the NYSE will improve our visibility in the global investment community, the world’s largest global equities market, and give us access to a broader investor base,” concluded Mr. Murphy. “We are privileged to welcome Bentley Pharmaceuticals to our family of NYSE-listed companies,” said NYSE President and co-COO Catherine R. Kinney. “We look forward to building a partnership with Bentley Pharmaceuticals and its investors.”

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Antibiotic resistance threatens millions of lives worldwide